Clinical Trials · NCT07610733
Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients.
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Fudan University
- Enrollment
- 100
- Start date
- Jun 2026
- Locations
- See registry
- Primary endpoint
- Proportion of Participants with E2 <30 pg/mL at 3 Months